Sales of Alprazolam Medicine Is Expected to Record a CAGR of Around 2.7% Over the Forcast Period
The demand for benzodiazepine drugs is expected to record a pedestrian CAGR of around 2.7% during the forecast period (2020-2026). The U.S. is expected to account for around one-third of the total share in the global benzodiazepine drugs market by 2026. Growing prevalence of anxiety in parallel with rising awareness regarding benzodiazepine drugs is reflecting on increasing opportunities for players in the U.S. market. As per a report by the Anxiety and Depression Association of America (ADAA), each year, over 40 Mn adults in the U.S. suffer from anxiety disorders.
A comprehensive study by Fact.MR opines that demand for benzodiazepine drugs would remain high-albeit generic ones-which would drive voluminous sales, though contribute moderately to market value.
For detailed insights on enhancing your product footprint, request for a sample here-
Presence of a large number of hospital and retail pharmacies further makes it easy for individuals to purchase benzodiazepine drugs. A significant influence of high concentration of leading players is also auguring well for the U.S. benzodiazepine drugs market, which has been discussed in detail, in a recent Fact.MR study.
A subject matter expert at Fact.MR opines, “Regulations regarding development of benzodiazepine drugs are relatively stringent in developed regions such as North America and Europe, which opens ground for branded as well as generic drugs in developing regions. As a result, entry barriers in developed regions would be high, while those in developing regions would be moderate.”
Key Highlights of Benzodiazepine Drugs Market Study
- Easy accessibility is a key feature driving substantial sales of benzodiazepine drugs through retail pharmacies. By 2026, these pharmacies are projected to record value tantamount to US$ 1.4 Bn. Additionally, sales prospects for benzodiazepine drugs are likely to grow during the forecast period, as consumers are evincing high interest in online pharmacies.
- Popularity of short-acting benzodiazepine drugs is expected to increase during the forecast period, as these induce less hangover effect and take relatively short time of action. On the back of this, around 77% of the total share would be attributable to the sales of short-acting benzodiazepine drugs.
- Being a highly prevalent disorder among individuals leading a demanding lifestyle, anxiety is projected to account for a sizeable share tantamount to around 53% in the benzodiazepine drugs market during the forecast period.
- Reduction in the number of prescriptions for benzodiazepine drugs, especially in countries such as the U.S., the U.K., and Canada, would impede market growth during the forecast period.
Need more information about Report Methodology? Click here- https://www.factmr.com/connectus/sample?flag=RM&rep_id=4432
Benzodiazepine Drugs Market – Assessment of Key Segments
|Time of Action||
Full Access of this Exclusive Report is Available at- https://www.factmr.com/checkout/4432
High Popularity of Generic Drugs Puts Pressure on Branded Products of Leading Players
The benzodiazepine drugs market features fragmentation, as leading players operate under the constant pressure of patent expiration of branded products. High investments made towards the development of innovative and new products by leading players intensifies pressure to achieve the desired RoI. For instance, in 2017, F.Hoffmann-La Roche AG invested around one-fifth of the total revenue to strengthen the pipeline of innovative products. Stringent regulations on innovative drugs further make it difficult for leading players to gain desired marketability.
On the other side, the focus of prominent and leading players is on achieving better penetration into the benzodiazepine drugs market through the development of generic drugs. Growing sales of generic benzodiazepine drugs are putting pressure on leading players to squeeze their profit margins and adopt a cost-competitive strategy to have better sales prospects.
Find More Valuable Insights on Benzodiazepine Drugs Market
Fact.MR, in its new offering, brings to the fore an unbiased analysis of the global benzodiazepine drugs market, presenting historical demand data (2016-2019), and forecast statistics for the period of 2020-2026. The study divulges compelling insights on the benzodiazepine drugs market on the basis of distribution channel (hospital pharmacies, retail pharmacies, and others), time of action (ultra-short acting, short acting, and long acting), application (anxiety, seizures, insomnia, alcohol withdrawal, and others), and product (alprazolam, clonazepam, diazepam, lorazepam, and others), across five major regions.
Explore More Trending Reports of Fact.MR
Pelvic Floor Stimulator Market Forecast, Trend Analysis & Competition Tracking – Global Review 2021 to 2031 ( https://www.factmr.com/report/pelvic-floor-stimulator-market )
Terminal Sterilization Market Forecast, Trend Analysis & Competition Tracking – Global Review 2021 to 2031 ( https://www.factmr.com/report/terminal-sterilization-market )
Cardiac Patch Monitor Market – Global Industry Analysis 2016 – 2020 and Opportunity Assessment 2021 – 2031 (https://www.factmr.com/report/cardiac-patch-monitor-market )
Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. We have offices in the US and Dublin, whereas our global headquarter is in Dubai. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have in our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Reach out to us with your goals, and we’ll be an able research partner.
US Sales Office:
11140 Rockville Pike
Rockville, MD 20852
Tel: +1 (628) 251-1583
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates
Content Source: https://www.factmr.com/media-release/1212/benzodiazepine-drugs-demand